Skip to main content

Yun Joo Lim

Kyung Hee University · 医学

研究室紹介

Professor Yun Joo Lim's research lab focuses on critical care and pulmonary medicine, with a strong emphasis on understanding the pathophysiology of sepsis and interstitial lung abnormalities in surgical and intensive care settings. The lab investigates novel biomarkers—particularly exosomes and their surface proteins like CD63—to predict organ failure, mortality, and postoperative complications in critically ill patients. Key research directions include identifying high-risk patients through imaging markers (e.g., interstitial lung abnormalities on CT) and developing predictive tools for early intervention in conditions like bronchiectasis and lung cancer. The lab integrates clinical data with molecular analysis to improve patient outcomes through precision medicine approaches.

sepsis biomarkersexosomespostoperative complicationsinterstitial lung abnormalitiescritical care

Research Overview

Papers
67
Total Citations
1,017
Papers (5y)
39
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
39total
2022
2023
2024
2025
2026
Citations per year (5y)
415total
20222023202420252026

Selected Papers

15
1
Article|152 citations·2022
Time-to-antibiotics and clinical outcomes in patients with sepsis and septic shock: a prospective nationwide multicenter cohort study
Yunjoo Im, Danbee Kang, Ryoung‐Eun Ko, Yeon Joo Lee, Sung Yoon Lim, Sunghoon Park, Soo Jin Na, Chi Ryang Chung, Mi Hyeon Park, Dong Kyu Oh, Chae‐Man Lim, Gee Young Suh
SJR Q1Critical CareOA

BACKGROUND: Timely administration of antibiotics is one of the most important interventions in reducing mortality in sepsis. However, administering antibiotics within a strict time threshold in all patients suspected with sepsis will require huge amount of effort and resources and may increase the risk of unintentional exposure to broad-spectrum antibiotics in patients without infection with its consequences. Thus, controversy still exists on whether clinicians should target different time-to-an

EpidemiologyMedicine
2
Article|75 citations·2019
Prevalence of and risk factors for pulmonary complications after curative resection in otherwise healthy elderly patients with early stage lung cancer
Yunjoo Im, Hye Yun Park, Sumin Shin, Sun Hye Shin, Hyun Lee, Joonghyun Ahn, Insuk Sohn, Jong Ho Cho, Hong Kwan Kim, Jae Ill Zo, Young Mog Shim, Ho Yun Lee
SJR Q1Respiratory ResearchOA

Curative resection for NSCLC in healthy elderly patients appeared feasible with 10% PPCs. ASA classification ≥3, lower BMI, presence of ILA on CT, and larger extent of resection are predictors of PPC development, which guide treatment decision-making in these patients.

Pulmonary and Respiratory MedicineMedicine
3
Article|47 citations·2020
Association of plasma exosomes with severity of organ failure and mortality in patients with sepsis
Yunjoo Im, Hongseok Yoo, Jin Young Lee, Junseon Park, Gee Young Suh, Kyeongman Jeon
SJR Q2Journal of Cellular and Molecular MedicineOA

Current sepsis biomarkers may be helpful in determining organ failure and evaluating patient clinical course; however, direct molecular biomarkers to predict subsequent organ failure have not yet been discovered. Exosomes, a small population of extracellular vesicles, play an important role in the inflammatory response, coagulation process and cardiac dysfunction in sepsis. Nonetheless, the association of plasma exosome with severity and mortality of sepsis is not well known. Therefore, the over

Molecular BiologyBiochemistry, Genetics and Molecular Biology
4
Article|41 citations·2021
Impact of Time Between Diagnosis and Treatment for Nontuberculous Mycobacterial Pulmonary Disease on Culture Conversion and All-Cause Mortality
Yunjoo Im, Na Young Hwang, Kyunga Kim, Hojoong Kim, O Jung Kwon, Byung Woo Jhun
SJR Q1CHEST Journal
EpidemiologyMedicine
5
Article|35 citations·2019
Development of tuberculosis in cancer patients receiving immune checkpoint inhibitors
Yunjoo Im, Jeeyun Lee, Seok Jin Kim, Won‐Jung Koh, Byung Woo Jhun, Se‐Hoon Lee
SJR Q1Respiratory Medicine
OncologyMedicine
6
Article|31 citations·2022
Impact of interstitial lung abnormalities on postoperative pulmonary complications and survival of lung cancer
Yunjoo Im, Man Pyo Chung, Kyung Soo Lee, Joungho Han, Myung Jin Chung, Hong Kwan Kim, Jong Ho Cho, Yong Soo Choi, Sujin Park, Ho Joong Kim, O Jung Kwon, Boram Park
SJR Q1ThoraxOA

BACKGROUND: Interstitial lung abnormalities (ILAs) are associated with the risk of lung cancer and its mortality. However, the impact of ILA on treatment-related complications and survival in patients who underwent curative surgery is still unknown. RESEARCH QUESTION: This study aimed to evaluate the significance of the presence of computed tomography-diagnosed ILA and histopathologically matched interstitial abnormalities on postoperative pulmonary complications (PPCs) and the long-term surviva

Pulmonary and Respiratory MedicineMedicine
7
Article|25 citations·2021
Exosomal CD63 in critically ill patients with sepsis
Yunjoo Im, Hongseok Yoo, Ryoung‐Eun Ko, Jin Young Lee, Junseon Park, Kyeongman Jeon
SJR Q1Scientific ReportsOA

CD63 is one of the tetraspanin protein family members that is ubiquitously expressed on exosomes and is involved in the signal transduction of various types of immune cells. It may thus contribute to immunometabolic mechanisms of cellular and organ dysfunction in sepsis. Nonetheless, the association of exosomal CD63 with the severity and mortality of sepsis is not well known. Therefore, in the present study, the overall levels of exosomal CD63 were evaluated to ascertain whether they were associ

Molecular BiologyBiochemistry, Genetics and Molecular Biology
8
Article|16 citations·2024
Disease Severity and Activity in Bronchiectasis: A Paradigm Shift in Bronchiectasis Management
Yunjoo Im, James D. Chalmers, Hayoung Choi
SJR Q2Tuberculosis & respiratory diseasesOA

Bronchiectasis has an increasing prevalence and substantial clinical and economic burden. Therefore, physicians should identify patients with bronchiectasis at high risk of disease progression to ensure optimal management in advance. The heterogeneity of bronchiectasis means it is unlikely that any single parameter could identify highrisk patients; therefore, disease severity is usually assessed using validated composite tools, such as the Bronchiectasis Severity Index, FACED, and Bronchiectasis

Pulmonary and Respiratory MedicineMedicine
9
Preprint|15 citations·2021
Time-To-Antibiotics and Clinical Outcomes in Patients With Sepsis and Septic Shock: A Prospective Nationwide Multicenter Cohort Study
Yunjoo Im, Danbee Kang, Ryoung‐Eun Ko, Yeon Joo Lee, Sung Yoon Lim, Sunghoon Park, Soo Jin Na, Chi Ryang Chung, Mi Hyeon Park, Dong Kyu Oh, Chae‐Man Lim, Gee Young Suh
Research SquareOA

<title>Abstract</title> Background It is unclear whether the administration of antibiotics within 1 hour could improve patient outcomes in sepsis, and whether the association of time to antibiotics administration and clinical outcomes are different for sepsis and septic shock. Methods This study analyzed prospectively collected data from an ongoing multicenter cohort of patients with sepsis identified in the emergency department. Adjusted odds ratios (ORs) were compared for in-hospital mortality

EpidemiologyMedicine
10
Article|14 citations·2021
Impact of treatment duration on recurrence of chronic pulmonary aspergillosis
Yunjoo Im, Byung Woo Jhun, Eun‐Suk Kang, Won‐Jung Koh, Kyeongman Jeon
SJR Q1Journal of Infection
Infectious DiseasesMedicine
11
Article|13 citations·2021
Prognosis of pulmonary lymphangitic carcinomatosis in patients with non-small cell lung cancer
Yunjoo Im, Hyewon Lee, Ho Yun Lee, Sun‐Young Baek, Byeong‐Ho Jeong, Kyungjong Lee, Hojoong Kim, Oh‐Jung Kwon, Joungho Han, Kyung Soo Lee, Myung‐Ju Ahn, Young Tae Kim
SJR Q1Translational Lung Cancer ResearchOA

The subjects with cLy1/2 had better overall survival than those with cLy3/4 or intrapulmonary metastases. cLy1/2 seems to be a T descriptor (T3/4) rather than an M1 descriptor.

Pulmonary and Respiratory MedicineMedicine
12
Article|9 citations·2023
Outcomes of Intermittent Multidrug IV Therapy for Refractory Mycobacterium abscessus Pulmonary Disease
Yunjoo Im, Su‐Young Kim, Dae Hun Kim, Byung Woo Jhun
SJR Q1CHEST Journal
EpidemiologyMedicine
13
Article|6 citations·2023
Impact of preserved ratio impaired spirometry on coronary artery calcium score progression: a longitudinal cohort study
Yunjoo Im, Hye Yun Park, Jin-Young Lee, Hyunsoo Kim, Hongseok Yoo, Mira Kang, Soo Jin Cho, Jung Hye Hwang, Yong Bum Park, Juhee Cho, Danbee Kang, Sun Hye Shin
SJR Q1ERJ Open ResearchOA

Background Preserved ratio impaired spirometry (PRISm) is associated with increased cardiovascular disease (CVD) risk and mortality. However, a causal relationship between PRISm and CVD remains unclear. We investigated the progression of coronary artery calcium (CAC) scores based on the presence of PRISm and reduced forced vital capacity (FVC). Methods This retrospective cohort study included 11 420 participants aged ≥40 years with forced expiratory volume in 1 s (FEV 1 )/FVC ≥0.7 who underwent

Cardiology and Cardiovascular MedicineMedicine
14
Article|5 citations·2024
Association of Preserved-Ratio Impaired Spirometry (PRISm) with All-Cause Mortality: A Longitudinal Cohort Study
Yunjoo Im, Taeyun Kim, Jung Hye Hwang, Hyunsoo Kim, Seokmin Hyun, So Rae Kim, Sun Hye Shin, Juhee Cho, Danbee Kang, Hye Yun Park
SJR Q1Annals of the American Thoracic Society

Abstract Rationale Numerous studies indicate that preserved-ratio impaired spirometry (PRISm) is associated with adverse clinical outcomes. However, the impact of PRISm severity, particularly in regard to forced vital capacity (FVC), on mortality risk remains unclear. Objectives To determine whether PRISm was associated with mortality and to identify specific groups with particularly increased mortality rates. Methods This retrospective study enrolled individuals aged &amp;gt;40 years who underw

Pulmonary and Respiratory MedicineMedicine
15
Article|3 citations·2024
Causal inference analysis of the radiologic progression in the chronic obstructive pulmonary disease
Yunjoo Im, Kwonsang Lee, Sang Min Lee, Sun Hye Shin, Yeonseok Choi, Jae‐Seung Lee, Yeon‐Mok Oh, Jong‐Hoon Kim, You Jin Oh, Ho Yun Lee, Hye Yun Park
SJR Q1Scientific ReportsOA

There is limited evidence regarding the causal inference of emphysema and functional small airway disease in the subsequent progression of chronic obstructive pulmonary disease (COPD). Patients consisting of two independent cohorts diagnosed with COPD and underwent two serial chest CT scans were included. Total percent emphysema (PRM Emph ) and fSAD (PRM fSAD ) was quantified via PRM. To investigate the progression of emphysema, we divided COPD patients with PRM Emph < 10% into low and high PRM

Pulmonary and Respiratory MedicineMedicine

Research Areas

Pulmonary and Respiratory MedicineEpidemiologyMolecular BiologyOncologySurgeryClinical Biochemistry

Yun Joo Limの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。